Parkinson's disease (PD) is a chronic, progressive neurodegenerative disorder affecting approximately 1% of individuals aged 60 and above. The disease is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to motor and non-motor symptoms.
The hallmark pathological feature of PD is the presence of Lewy bodies, abnormal aggregates of the protein alpha-synuclein, in the remaining dopaminergic neurons. The exact mechanism of neuronal death is still under investigation, but it is believed that oxidative stress, mitochondrial dysfunction, and protein misfolding all play a role. The loss of dopamine in the basal ganglia results in an imbalance of excitatory and inhibitory signals, leading to the characteristic motor symptoms of PD.
PD presents with a combination of motor symptoms (tremor, bradykinesia, rigidity, and postural instability) and non-motor symptoms (depression, cognitive impairment, and autonomic dysfunction). Diagnosis is primarily clinical, based on the presence of motor symptoms and response to dopaminergic medications. Neuroimaging can be useful in uncertain cases, but is not routinely recommended.
Management of PD is multidimensional, involving pharmacological and non-pharmacological approaches. Pharmacological treatment is centered around augmenting dopamine levels in the brain, primarily through the use of levodopa. Non-pharmacological strategies include physical therapy, occupational therapy, and speech therapy. Deep brain stimulation is an option for patients with advanced disease and severe motor fluctuations.
Understanding the pathophysiology and management of PD is crucial for healthcare professionals to provide optimal care for these patients. While there is currently no cure for PD, ongoing research promises the potential for new therapeutic strategies in the future.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation